Erasca, Inc. · NASDAQ:ERAS

Paradigm Biocapital Advisors LP reported a 5.30% stake in Erasca, Inc. (Schedule 13G)

Event Jan 7, 2026 · Filed Jan 14, 2026

Paradigm Biocapital Advisors LP reported a 5.30% stake in Erasca, Inc., 15,159,095 shares, as a passive investor on Jan 7, 2026. Filed Jan 14, 2026 (Schedule 13G).

Stake
5.30%
Shares
15,159,095
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP5.30%15,159,095
Paradigm BioCapital Advisors GP LLC5.30%15,159,095
Senai Asefaw, M.D.5.30%15,159,095
Paradigm BioCapital International Fund Ltd.4.70%13,377,027

Source

View original at SEC

Related